← All candidates
8 insider filings on record.
17 filings on record.
CMPXCompass Therapeutics, Inc.
NasdaqCM · Healthcare · $428.61M
$2.38
-5.61% · Sep 15
8 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily◆ 2 8-K
▸ hover a marker for the filing · drag to zoom · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$428.61M
Float
132.4M
74% public
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
CHIEF EXECUTIVE OFFICER
Schuetz Thomas J.
Bought $21.1K on May 27 — 10,000 sh @ $2.11, held direct, 0.2% of their stake.
First Form 4 on file
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
3 more transactions on Pro →The file stays open
17 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice